FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Marksans Pharma Ibuprofen Tablets Recall

Ibuprofen Tablets, USP 400 mg, 6 x 3500 Tablets bulk packed in double polybag shipper p…

Marksans Pharma Inc. · Hauppauge, NY

Risk level
Class II
Reported by FDA
Jan 31, 2018
Recall ID
D-0238-2018
Check your lot numberHow we source this data

Summary

Marksans Pharma recalled Ibuprofen Tablets starting Jan 9, 2018. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0238-2018 on Jan 31, 2018. Reason: CGMP Deviations: Various strengths of ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies. Status: Terminated.

Why it was recalled

CGMP Deviations: Various strengths of ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies.

Product description

Ibuprofen Tablets, USP 400 mg, 6 x 3500 Tablets bulk packed in double polybag shipper packs for further packaging, Rx only, Manufactured by: Marksans Pharma Ltd., Plot No. L-82, L-83, Verna Indl. Estate, Verna, Goa - 403 722, India, NDC 25000-121-29.

Lot numbers, UPCs & expiration codes

Lot #: HK6001, HK6002, HK6003, HK6004, HK6005, HK6006, HK6007, HK6008, HK6009, HK6010, HK6011, HK6012, HK6013, HK6014, HK6015, Exp 09/18

Where it was sold

Distributed to repackaging firms in NY who then distributed Nationwide in the USA.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0238-2018
Classification
Class II
Status
Terminated
Recall initiated
Jan 9, 2018
FDA report date
Jan 31, 2018
Quantity
21,584,100 tablets
Recall type
Voluntary: Firm initiated
Recalling firm
Marksans Pharma Inc.

Original FDA data

Every field from FDA enforcement report D-0238-2018, exactly as published.

Show all FDA fields
City
Hauppauge
State
NY
Status
Terminated
Country
United States
Event ID
78822
Address
Suite # 401, 4th Floor
Address (line 2)
Room No. 430, 150 Motor Parkway
Code information
Lot #: HK6001, HK6002, HK6003, HK6004, HK6005, HK6006, HK6007, HK6008, HK6009, HK6010, HK6011, HK6012, HK6013, HK6014, HK6015, Exp 09/18
Postal code
11788
Report date
Jan 31, 2018
Product type
Drugs
Recall number
D-0238-2018
Classification
Class II
Recalling firm
Marksans Pharma Inc.
Product quantity
21,584,100 tablets
Termination date
May 26, 2020
Reason for recall
CGMP Deviations: Various strengths of ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Ibuprofen Tablets, USP 400 mg, 6 x 3500 Tablets bulk packed in double polybag shipper packs for further packaging, Rx only, Manufactured by: Marksans Pharma Ltd., Plot No. L-82, L-83, Verna Indl. Estate, Verna, Goa - 403 722, India, NDC 25000-121-29.
Distribution pattern
Distributed to repackaging firms in NY who then distributed Nationwide in the USA.
Recall initiation date
Jan 9, 2018
Initial firm notification
Letter
Center classification date
Jan 24, 2018

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0238-2018, published Jan 31, 2018. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls